The role of vitamin D in the prevention and treatment of osteoporosis

Clinical Reviews in Bone and Mineral Metabolism

Volumn 2, Issue 4, 2004, Pages 373-388

  Elliott, Mary E ^a   Nolan, Nicole M ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Calcitriol; Calcium; Osteomalacia; Osteoporosis; Sunlight; Vitamin D; Vitamin D receptor

Indexed keywords

2BETA (3 HYDROXYPROPOXY)CALCITRIOL; ALENDRONIC ACID; ALFACALCIDOL; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIPOTRIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; ESTROGEN; HORMONE; PARATHYROID HORMONE[1-34]; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

BIOLOGY; BONE DENSITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG INTERACTION; DRUG MECHANISM; DRUG USE; FRAGILITY FRACTURE; HEART FAILURE; HUMAN; HYPERCALCEMIA; MULTIPLE SCLEROSIS; OSTEOPOROSIS; PATIENT COUNSELING; PATIENT SELECTION; REVIEW; SKELETON; TRANSPORT KINETICS; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

EID: 27544470512     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:2:4:373     Document Type: Review

References (105)

1. Holick MF. 2003 Vitamin D: Photobiology, metabolism, mechanism of action, and clinical applications. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. Favus MJ, ed. American Society for Bone and Mineral Research, Washington, DC,pp. 129-137.
2. Holick MF, Adams JS. 1998 Vitamin D metabolism and biological function. In: Metabolic Bone Disease and Clinically Related Disorders, 3rd ed. Avioli LV, Krane SM, eds. Academic Press, San Diego, CA, pp. 123-164.
3. Bouillion R. 2001 Vitamin D: From photosynthesis, metabolism, and action to clinical applications. In: Endocrinology, 4th ed. DeGroot L, Jameson LJ, eds. W.B. Saunders & Co, Philadelphia,PA, pp. 1009-1028.
4. McKenna MJ, Freaney R. 1998 Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8(Suppl 2:S3-S6.
5. Parfitt AM, Gallagher JC, Heaney RP, Johnson CC, Neer P, Whedon G. 1982 Vitamin D and bone disease in the elderly. Am J Clin Nutr 36:1014-1031.
6. Peacock M, Selby PL, Francis RM, Brown WB, Hordon L. 1985 Vitamin D deficiency, insufficiency, and intoxication. What do they mean? In: Vitamin D: Chemical, Biochemical and Clinical Update. Norman AW, Schaefer K, Grigoleit H-G, Herrath D, eds. Walter de Gruyter, Berlin, pp. 569-570.
7. Heaney RP, Weaver CM. 2003 Calcium and vitamin D. Endocrinol Metab Clin North Am 32:181-194.
8. Heaney RP, Dowell MS, Hale CA, Bendich A. 2003 Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22:142-146.
9. Chen TC. Photobiology of vitamin D. In: Vitamin D: Physiology, Molecular Biology, & Clinical Applications. Holick, MF, ed. Humana Press, Totowa, NJ, pp. 17-36.
10. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. 1987 Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64:1165-1168.
11. Fonseca V, Tongia R, el-Hazmi M, Abu-Aisha H. 1984 Exposure to sunlight and vitamin D deficiency in Saudi Arabian women. Postgrad Med J 60:589-591.
12. Stokstad E. 2003 Nutrition. The vitamin D deficit. Science 302:1886-1888.
13. Holick MF. 1995 Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 61(Suppl 3):638S-645S.
14. Pasco JA, Henry MJ, Kotowicz MA, et al. 2004 Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 19:752-758
15. Chen TC, Shao A, Heath H 3rd, Holick MF. 1993 An update on the vitamin D content of fortified milk from the United States and Canada. N Engl J Med 329:1507
16. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. 1972 The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43:413-431.
17. Omdahl JL, Morris HA, May BK. 2002 Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Ann RevNutrition 22:139-166.
18. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. 2003 De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J Biol Chem 278:38,084-38,093.
19. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. 2004 Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 101:7711-7715.
20. Gupta RP, Hollis BW, Patel SB, Patrick KS, Bell NH. 2004 CYP3A4 is a human microsomal vitamin D 25-hydroxylase J Bone Miner Res 19:680-688
21. Watts GF, Mitchell WD, Bending JJ, Reshef A, Leitersdorf E. 1996 Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy. QJM 89:55-63.
22. Rystedt E, Olin M, Seyama Y, et al. 2002 Cerebrotendinous xanthomatosis: molecular characterization of two Scandinavian sisters. J Intern Med 252:259-264.
23. Taylor AB. Stern PH. Bell NH. 1982 Abnormal regulation of circulating 25-hydroxyvitamin D in the Williams syndrome. N Engl J Med 306:972-975.
24. Kitagawa H, Fujiki R, Yoshimura K, et al. 2003 The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113:905-917.
25. 3 in humans. Endocrinology;145(Suppl): abstract OR 22-2.
26. Quarles LD. 2003 Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest 112:642-646.
27. Brown AJ. 2001 Therapeutic uses of vitamin D analogues. Am J Kidney Dis 38(Suppl 5):S3-S19.
28. Lian JB, Staal A, van Wijnen A, Stein JL, Stein GS. 1998 Biology and molecular effects of vitamin D on bone. In: Vitamin D: Physiology, Molecular Biology, & Clinical Applications. Holick, MF, ed. Humana Press, Totowa, NJ, pp. 1-16.
29. Ralston SH. 2002 Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 87:2460-2466.
30. Ferrari SL, Rizzoli R, Slosman DO, Bonjour JP. 1998 Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms? J Bone Miner Res 13:363-370.
31. Arai H, Miyamoto KI, Yoshida M, et al. 2001 The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res 16:1256-1264.
32. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Institute of Medicine. 1997 Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, D.C., National Academy Press, pp. 250-374.
33. Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 Suppl): S1-S34.
34. American College of Rheumatology. 2001 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 44:1496-1503.
35. Anonymous. 1998 Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int 8(Suppl 4):1-88.
36. American Association of Clinical Endocrinologists. 2001 American Association of Clinical Endocrinologists. Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. Available at: http://www.aace.com/clin/guidelines/osteoporosis2001.pdf. Accessed July 1, 2004.
37. Hollis BW. 1996 Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 58:4-5.
38. Tangpricha V, Pearce EN, Chen TC, Holick MF. 2002 Vitamin D insufficiency among free-living healthy young adults. Am J Med 112:659-662,
39. Prentice A. 2002 What are the dietary requirements for calcium and vitamin D? Calcif Tissue Int 70:83-88.
40. Osler M. Heitmann BL. 1998 Food patterns, flour fortification, and intakes of calcium and vitamin D: a longitudinal study of Danish adults. J Epidemiol Community Health 52:161-165.
41. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. 2002 Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 76:187-192.
42. O'Dowd KJ, Clemens TL, Kelsey JL, Lindsay R. 1993 Exogenous calciferol (vitamin D) and vitamin D endocrine status among elderly nursing home residents in the New York City area. J Am Geriatr Soc 41:414-421.
43. Elliott ME, Binkley NC, Carnes M, et al. 2003 Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy 23:702-710.
44. Dawson-Hughes B. 1999 Calcium and vitamin D nutrition. In: Osteoporosis in Men. The Effects of Gender on Skeletal Health. Orwoll ES, ed. Academic Press, San Diego, CA, pp. 197-209.
45. Valimaki VV, Alfthan H, Lehmuskallio E, et al. 2004 Vitamin D status as a determinant of peak bone mass in young Finnish men. J Clin Endoc Metab 89:76-80.
46. Awumey EM, Mitra DA, Hollis BW, Kumar R, Bell NH. 1998 Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study. J Clin Endoc Metab 83:169-173.
47. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. 2002 Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771-777.
48. Malabanan AO, Holick MF. 2003 Vitamin D and bone health in postmenopausal women. J Womens Health 12:151-156.
49. Trivedi DP, Doll R, Khaw KT. 2003 Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 326:469-474.
50. Heikinheimo RJ, Inkovaara JA, Harju EJ, et al. 1992 Annual infection of vitamin D and fractures of aged bones. Calcif Tissue Int 51:105-110.
51. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med 337:670-676.
52. Chapuy MC, Arlot ME, Duboeuf F, et al. 1992 Vitamin D and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637-1642.
53. Chapuy MC, Arlot ME, Delmans PD, Meunier PJ. 1994 Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308:1081-1082.
54. Larsen EJ, Mosekilde L, Foldspang A. 2004 Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Min Res 19:370-378.
55. Lips P, Graafmans WC, Ooms ME, Bezemer D, Bouter LM. 1996 Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial Ann Intern Med 124:400-406.
56. Papadimitropoulos E, Wells G, Shea B, et al. 2002 VIII: meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560-569.
57. Ooms ME, Roos JC, Bezemer D, Van Der Vijgh WJF, Bouter LM, Lips P. 1995 Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80:1052-1058.
58. Harris ST, Watts NB, Genant HK, et al. 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA 282:1344-1352.
59. Reginster J, Minne HW, Sorensen OH, et al. 2000 Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporosis Int 11:83-91.
60. Black DM, Cummings SR, Karpf DB, et al. 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541.
61. Liberman UA, Weiss SR, Broll J, et al. 1995 Effect of oral alendronate on bone mineral density N Engl J Med 333:1437-1443.
62. Ettinger B, Black DM, Mitlak BH, et al. 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 282:637-645.
63. Chesnut CH, Silverman S, Andriano K, et al. 2000 A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 109:267-276.
64. Neer RM, Arnaud CD, Zanchetta JR, et al. 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.
65. Orwoll E, Ettinger M, Weiss S, et al. 2000 Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604-610.
66. Orwoll ES, Scheele WH, Paul S, et al. 2003 The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18:9-17.
67. Ebeling PR, Wark JD, Yeung S, et al. 2001 Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteopososis: a two-year randomized, double-blind, double placebo study. J Clin Endocrinol Metab 86:4098-4103.
68. Richy F, Ethgen O, Bruyere O, Reginster JY. 2004 Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 15:301-310.
69. Hauselmann HJ, Rizzoli R. 2003 A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos Int 14:2-12.
70. Tilyard MW, Spears GF, Thomson J, Dovey S 1992 Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357-362.
71. Jones G, Hogan DB, Yendt E, Hanley DA. 1996 Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. CMAJ 155:955-961.
72. Kubodera N, Tsuji N, Uchiyama Y, Endo K. 2003 A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients. J Cell Biochem 88:286-289.
73. Vazquez G, de Boland AR, Boland R. 1997 Stimulation of Ca2+ release-activated Ca2+ channels as a potential mechanism involved in non-genomic 1,25(OH)2-vitamin D3-induced Ca2+ entry in skeletal muscle cells. Biochem Biophys Res Commun 239:562-565.
74. Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. 2004 Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 19:265-269.
75. Gloth FM 3rd, Smith CE, Hollis BW, Tobin JD. 1995 Functional improvement with vitamin D replenishment in a cohort of frail, vitamin D-deficient older people. J Am Geriatr Soc 43:1269-1271.
76. Prabhala A, Garg R, Dandona P. 2000 Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 160:1199-1203.
77. Glerup H, Mikkelsen K, Poulsen L, et al. 2000 Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419-424.
78. Stein MS, Wark JD, Scherer SC, et al. 1999 Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 47:1195-1201.
79. Dhesi JK, Bearne LM, Moniz C, et al. 2002 Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 17:891-897.
80. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. 2000 Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15:1113-1118.
81. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. 2003 Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41:105-112.
82. Munger KL, Zhang SM, O'Reilly E, et al. 2004 Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60-65.
83. Grant WB, Garland CF. 2004 A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 48:115-123.
84. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. 2004 Iowa Women's Health Study.Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50:72-77.
85. Pettifor JM. 2003 Nutritional and drug-induced rickets and osteomalacia. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism Favus MJ, ed. Lippincott Williams & Wilkins, Philadelphia, PA,pp 399-407.
86. Gloth FM 3rd, Tobin JD. 1995 Vitamin D deficiency in older people. J Am Geriatr Soc 43:822-828.
87. Vieth R, Ladak Y, Walfish PG. 2003 Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endoc Metab 88:185-191.
88. Pattanaungkul S, Riggs BL, Yergey AL, Vieira NE, O'Fallon WM, Khosla S. 2000 Relationship of intestinal calcium absorption to 1,25-dihydroxy vitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endoc Metab 85:4023-4027.
89. Reginato AJ, Coquia JA. 2003 Musculoskeletal manifestations of osteomalacia and rickets. Best Pract Res Clin Rheumatol 17:1063-1080.
90. Basha B, Rao DS, Han ZH, Parfitt AM. 2000 Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med 108:296-300.
91. Lo CW, Paris PW, Clemens TL, Nolan J, Holick MR 1985 Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr 42:644-649.
92. Tovey FI, Hall ML, Ell PJ, Hobsley M. 1992 A review of postgastrectomy bone disease. J Gastroenterol Hepatol 7:639-645.
93. NKF K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. 2003 http://www.kidney.org/professionals/kdoqi/ guidelines_bone/index.htm. Accessed July 1, 2004.
94. Hewison M, Kantorovich V, Liker HR, et al. 2003 Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18:579-582.
95. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. 1998 Hypovitaminosis D in medical inpatients. N Engl J Med 338:777-783.
96. Barger-Lux, MJ, Heaney RP. 2002 Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87:4952-4956.
97. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. 2003 Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204-210.
98. Heaney RP. 2000 Vitamin D: How much do we need, and how much is too much? Osteoporos Int 11:553-555.
99. Adams JS, Kantorovich V, Wu C, Javanbakht M, Hollis BW. 1999 Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endoc Metab 84:2729-2730.
100. Malabanan A, Veronikis IE, Holick MF. 1998 Redefining vitamin D insufficiency. Lancet. 351:805-806.
101. Vieth R. 1999 Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842-846.
102. Promislow JH, Goodman-Gruen D, Slymen DJ, Barrett-Connor E. 2002 Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study. J Bone Miner Res 17:1349-1358.
103. Reginster JY, Zegels B, Lejeune E, et al. 2002 Influence of daily regimen calcium and vitamin D supplementation on parathyroid hormone secretion. Calcif Tissue Int 70:78-82.
104. Hollis BW. 2000 Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 46:1657-1661.
105. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004 89:3152-3157.